TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Tillotts Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
270,687
|
307,810
|
235,569 |
Financial expenses |
3,069
|
132
|
1,326 |
Earnings before taxes |
2,894
|
7,736
|
3,885 |
EBITDA |
4,789
|
7,804
|
3,800 |
Total assets |
127,765
|
107,649
|
156,267 |
Current assets |
127,595
|
107,483
|
155,819 |
Current liabilities |
87,854
|
69,989
|
121,808 |
Equity capital |
30,507
|
28,304
|
24,280 |
- share capital |
67
![]() |
67
|
73 |
Employees (average) |
21
|
19
|
18 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
23.9%
|
26.3%
|
15.5% |
Turnover per employee |
12,890
|
16,201
|
13,087 |
Profit as a percentage of turnover |
1.1%
|
2.5%
|
1.6% |
Return on assets (ROA) |
4.7%
|
7.3%
|
3.3% |
Current ratio |
145.2%
|
153.6%
|
127.9% |
Return on equity (ROE) |
9.5%
|
27.3%
|
16.0% |
Change turnover |
-38,709
|
91,323
|
3,405 |
Change turnover % |
-13%
|
42%
|
1% |
Chg. No. of employees |
2
|
1
|
2 |
Chg. No. of employees % |
11%
|
6%
|
13% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.